Z Stock Recent News

Zillow (Z) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.36 per share a year ago.

CEO said the company's continued expansion of services and scaling of its “housing super app” to reach more real estate markets helped the company's top and bottom lines.

Zillow is expected to report its narrowest loss since it last turned a quarterly profit in 2022, according to FactSet.

Zillow (Z) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,281,056) directed to highly pure and stable enteric oral formulations comprising (Z)-endoxifen as well as therapeutic methods of using those oral formulations.

Brokerage will include Zillow Showcase in its innovative marketing suite to help agents elevate the listing experience for sellers SEATTLE , April 23, 2025  /PRNewswire/ -- Zillow® and Epique Realty today announced a product partnership that gives Epique agents access to Zillow Showcase ℠, an AI-powered listing experience exclusive to Zillow, as part of the brokerage's marketing suite. In offering Zillow Showcase to agents, Epique Realty is enhancing its recruiting and retention efforts by empowering agents to differentiate their brand and listings with innovative, tech-forward solutions.

SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today announced that the United States Patent and Trademark Office (USPTO) has granted a new patent (U.S. Patent No. 12,275,684) directed to enteric oral formulations comprising (Z)-endoxifen as well as methods of treating subjects with those oral formulations.

Z introduces a new advanced tool for Showcase listings, enabling sellers and agents to improve their selling strategies.

SEATTLE, April 15, 2025 /PRNewswire/ -- Zillow Group, Inc. (Nasdaq: Z and ZG) today announced it will release first-quarter 2025 financial results after market close on Wednesday, May 7, 2025. The company will host a webcast and conference call to discuss its results that afternoon at 2 p.m. PT / 5 p.m. ET.

Want more housing market stories from Lance Lambert's ResiClub in your inbox? Subscribe to the ResiClub newsletter.